Foto del docente

Michele Cavo

Alma Mater Professor

Alma Mater Studiorum - Università di Bologna

Adjunct professor

Department of Medical and Surgical Sciences

Publications

Ludwig H, Durie BG, McCarthy P, Palumbo A, San Miguel J, Barlogie B, Morgan G, Sonneveld P, Spencer A, Andersen KC, Facon T, Stewart KA, Einsele H, Mateos MV, Wijermans P, Waage A, Beksac M, Richardson PG, Hulin C, Niesvizky R, Lokhorst H, Landgren O, Bergsagel PL, Orlowski R, Hinke A, Cavo M, Attal M; International Myeloma Working Group., IMWG consensus on maintenance therapy in multiple myeloma., «BLOOD», 2012, 119, pp. 3003 - 3015 [Scientific article]

Brioli A;Zamagni E;Pasquali S;Tosi P;Tacchetti P;Perrone G;Pantani L;Petrucci A;Zannetti BA;Baccarani M;Cavo M, Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition disease., «BONE MARROW TRANSPLANTATION», 2012, 47, pp. 1248 - 1249 [Scientific article]

Zamagni E; Petrucci A; Tosi P; Tacchetti P; Perrone G; Brioli A; Pantani L; Zannetti B; Terragna C; Baccarani M; Cavo M., Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma., «ANNALS OF HEMATOLOGY», 2012, 91, pp. 419 - 426 [Scientific article]

Richardson PG; Delforge M; Beksac M; Wen P; Jongen JL; Sezer O; Terpos E; Munshi N; Palumbo A; Rajkumar SV; Harousseau JL; Moreau P; Avet-Loiseau H; Lee JH; Cavo M; Merlini G; Voorhees P; Chng WJ; Mazumder A; Usmani S; Einsele H; Comenzo R; Orlowski R; Vesole D; Lahuerta JJ; Niesvizky R; Siegel D; Mateos MV; Dimopoulos M; Lonial S; Jagannath S; Bladé J; Miguel JS; Morgan G; Anderson KC; Durie BG; Sonneveld P., Management of treatment-emergent peripheral neuropathy in multiple myeloma., «LEUKEMIA», 2012, 26, pp. 595 - 608 [Scientific article]

Morgan G; Johnsen HE; Goldschmidt H; Palumbo A; Cavo M; Sonneveld P; Miguel JS; Chim CS; Browne P; Einsele H; Waage A; Turesson I; Spencer A; Hajek R; Ludwig H; Hemminki K; Houlston R., MyelomA Genetics International Consortium., «LEUKEMIA & LYMPHOMA», 2012, 53, pp. 796 - 800 [Scientific article]

Musto P; Pagano L; Petrucci MT; Morabito F; Caravita T; Di Raimondo F; Baldini L; Tosi P; Bringhen S; Offidani M; Omede' P; Neri A; D'Auria F; Bochicchio GB; Cavo M; Boccadoro M; Palumbo A, Primary plasma cell leukemia in the era of new drugs: has something changed?, «CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY», 2012, 82, pp. 141 - 149 [Scientific article]

Moreau P; Richardson PG; Cavo M; Orlowski RZ; San Miguel JF; Palumbo A; Harousseau JL., Proteasome inhibitors in multiple myeloma: ten years later., «BLOOD», 2012, --, pp. 1 - 47 [Scientific article]

Kumar S.K.; Lee J.H.; Lahuerta J.J.; Morgan G.; Richardson P.G.; Crowley J.; Haessler J.; Feather J.; Hoering A.; Moreau P.; LeLeu X.; Hulin C.; Klein S.K.; Sonneveld P.; Siegel D.; Bladé J.; Goldschmidt H.; Jagannath S.; Miguel J.S.; Orlowski R.; Palumbo A.; Sezer O.; Rajkumar S.V.; Durie B.G. International Myeloma Working Group Abildgaard N; Abonour R; Alexanian R; Alsina M; Anderson KC; Attal M; Avet-Loiseau H; Badros A; Baris D; Barlogie B; Bataille R; Beksaç M; Belch A; Ben-Yehuda D; Bensinger B; Bergsagel PL; Bird J; Bladé J; Boccadoro M; Cavo M; Chanan-Khan A; Chen WM; Child T; Chim J; Chng WJ; Comenzo R; Crowley J; Dalton W; Davies F; de Souza C; Delforge M; Dimopoulos M; Dispenzieri A; Drach J; Drake M; Durie BG; Einsele H; Facon T; Fantl D; Fermand JP; Fonseca R; Gahrton G; García-Sanz R; Gasparetto C; Gertz M; Gibson J; Giralt S; Goldschmidt H; Greipp P; Hajek R; Hardan I; Hari P; Harousseau JL; Hata H; Hattori Y; Heffner T; Ho J; Hungria V; Ida S; Jacobs P; Jagannath S, Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study., «LEUKEMIA», 2012, 26, pp. 149 - 157 [Scientific article]

Barosi G; Merlini G; Billio A; Boccadoro M; Corradini P; Marchetti M; Massaia M; Tosi P; Palumbo A; Cavo M; Tura S., SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma., «ANNALS OF HEMATOLOGY», 2012, 91, pp. 875 - 888 [Scientific article]

Mancini; Elisa Leo; Elena Zamagni; Paola Tacchetti; Annamaria Brioli; Lucia Pantani; Beatrice Anna Zannetti; Giovanni Martinelli; Michele Cavo, SIRT Regulates the Molecular Interaction Between c-MYC and HIF-1α in Multiple Myeloma, in: Blood, «BLOOD», 2012, 120(21), pp. 574 - 574 (atti di: 54th ASH Annual Meeting, Atlanta, GA, December 8 – 11, 2012) [Abstract]

Elena Zamagni;Michele Cavo, The role of imaging techniques in the management of multiple myeloma, «BRITISH JOURNAL OF HAEMATOLOGY», 2012, 159, pp. 499 - 513 [Scientific article]

Cavo M., A third-generation IMiD for MM., «BLOOD», 2011, 118, pp. 2931 - 2932 [Comment or similar]

Terragna, C ; Remondini, D; Durante, S; Martello, M; Patriarca, F; Levi, A; Pantani, L; Donnarumma, D ; Crippa, C; Bringhen, S; Rambaldi, A ; Offidani, M; Corradini, P; Narni, F; Fioritoni, G; Zaccaria, A; Baldini, L; Caravita, T; La Nasa, G; Cortelazzo, S; Martinelli, G; Baccarani, M; Cavo, M, A 41-Gene Signature Predicts Complete Response (CR) to Bortezomib-Thalidomide-Dexamethasone (VTD) As Induction Therapy Prior to Autologous Stem-Cell Transplantation (ASCT) in Multiple Myeloma (MM), in: Blood, 2011, pp. 366 - 366 (atti di: 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), San Diego, CA, DEC 10-13, 2011) [Abstract]

Palumbo A.; Cavo M.; Bringhen S.; Zamagni E.; Romano A.; Patriarca F.; Rossi D.; Gentilini F.; Crippa C.; Galli M.; Nozzoli C.; Ria R.; Marasca R.; Montefusco V.; Baldini L.; Elice F.; Callea V.; Pulini S.; Carella A.M.; Zambello R.; Benevolo G.; Magarotto V.; Tacchetti P.; Pescosta N.; Cellini C.; Polloni C.; Evangelista A.; Caravita T.; Morabito F.; Offidani M.; Tosi P.; Boccadoro M., Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial., «JOURNAL OF CLINICAL ONCOLOGY», 2011, 29, pp. 986 - 993 [Scientific article]

Munshi N.C.; Anderson K.C.; Bergsagel P.L.; Shaughnessy J.; Palumbo A.; Durie B.; Fonseca R.; Stewart A.K.; Harousseau J.L.; Dimopoulos M.; Jagannath S.; Hajek R.; Sezer O.; Kyle R.; Sonneveld P.; Cavo M.; Rajkumar S.V.; San Miguel J.; Crowley J.; Avet-Loiseau H.; International Myeloma Workshop Consensus Panel 2., Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2, «BLOOD», 2011, 117, pp. 4696 - 4700 [Scientific article]